Doseology Sciences (MOOD) Price & Analysis

Compare

5 Followers

MOOD Stock Chart & Stats

C$0.53

C$0.00(0.00%)

At close: Dec 31 4:00 PM EST

C$0.53

C$0.00(0.00%)

Day’s Range― - ―

52-Week RangeC$0.12 - C$1.90

Previous CloseN/A

Volume0.00

Average Volume (3M)1.79K

Market Cap

C$4.89M

Enterprise ValueC$926.30K

Total Cash (Recent Filing)C$1.43M

Total Debt (Recent Filing)C$0.00

Price to Earnings (P/E)―

Beta-3.74

Next Earnings

Mar 02, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding8,011,621

10 Day Avg. Volume3,383

30 Day Avg. Volume1,793

Financial Highlights & Ratios

PEG Ratio-0.49

Price to Book (P/B)3.46

Price to Sales (P/S)113.73

P/FCF Ratio-14.14

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Low Leverage / Clean Balance SheetEffectively zero debt provides durable financial flexibility: it reduces solvency risk, preserves capacity to fund operations or M&A, and lets management prioritize product development or marketing without heavy interest burdens. Low leverage improves resilience across cycles.

Focused Consumer Cannabinoid Product StrategyA clear product focus on dosage-controlled, functional wellness cannabis products targets structural consumer demand in wellness markets. Branded consumer offerings can generate repeatable revenue and higher margin potential as scale, distribution and brand recognition build over months to years.

Improving Cash Burn TrendsMaterial improvement in cash burn shows management has tightened spending and is making operations more sustainable. This trend extends runway, lowers near-term funding pressure, and, if continued, can enable reinvestment toward commercialization and margin expansion.

Bears Say

Small, Volatile And Declining RevenueVery small, falling revenue materially limits the company’s ability to achieve scale economies or cover fixed costs. Persistent top-line volatility makes forecasting and long-term investment decisions harder, and constrains the path to profitable, self-sustaining operations.

Consistent Negative Operating And Free Cash FlowRecurring negative operating and free cash flow forces reliance on external financing to fund operations. Continued external funding needs can dilute shareholders, limit strategic optionality, and raise execution risk if capital access tightens over the next several quarters.

Ongoing Losses And Negative Returns On EquitySustained net losses and negative ROE indicate the business is not yet generating shareholder value. Over time continued erosion of equity and profitability can impair ability to attract long-term investors, making it harder to fund growth without dilutive capital raises.

Doseology Sciences News

Doseology Taps Veteran Pharmacy Executive Larry Latowsky as Executive Chairman to Steer Commercial Expansion

Doseology Sciences ( ($TSE:MOOD) ) just unveiled an update. Doseology Sciences has appointed veteran retail and healthcare executive...

2d ago

Doseology Launches Pilot for Caffeine Energy Pouches Under Feed That Brain Brand

Doseology Sciences ( ($TSE:MOOD) ) just unveiled an update. Doseology Sciences has begun a pilot production run of...

1M ago

Doseology Boosts Transparency With New Annual Information Form Filing

Doseology Sciences ( ($TSE:MOOD) ) has issued an update. Doseology Sciences Inc. has filed its Annual Information Form...

1M ago

Doseology Taps McKinney Advisors to Fast-Track Regulatory Path for Oral Pouch Line

Doseology Sciences ( ($TSE:MOOD) ) just unveiled an announcement. Doseology Sciences has entered a strategic partnership with McKinney...

1M ago

Doseology Launches Investor Communications Initiative to Boost Market Engagement

The latest update is out from Doseology Sciences ( ($TSE:MOOD) ). Doseology Sciences Inc. has launched an Investor...

3M ago

Doseology Secures Strategic Manufacturing Agreement for Market Readiness

Doseology Sciences ( ($TSE:MOOD) ) has issued an announcement. Doseology Sciences Inc. has announced a significant milestone with...

3M ago

Doseology Sciences Expands Portfolio with Strategic Acquisition

An update from Doseology Sciences ( ($TSE:MOOD) ) is now available. Doseology Sciences Inc. has completed the acquisition...

6M ago

Doseology Acquires ‘Feed That Brain’ and Appoints Joseph Mimran as Strategic Advisor

The latest announcement is out from Doseology Sciences ( ($TSE:MOOD) ). Doseology Sciences Inc. has acquired the ‘Feed...

6M ago

Doseology Appoints Industry Veteran as Strategic Advisor

Doseology Sciences ( ($TSE:MOOD) ) has issued an announcement. Doseology Sciences Inc. has appointed Patrick W. Sills as...

7M ago

Doseology Appoints New President & COO to Drive Stimulant Pouch Market Expansion

Doseology Sciences ( ($TSE:MOOD) ) has shared an announcement. Doseology Sciences Inc. has appointed Timothy Corkum as President...

8M ago

MOOD FAQ

What was Doseology Sciences, Inc.’s price range in the past 12 months?

Doseology Sciences, Inc. lowest stock price was C$0.12 and its highest was C$1.90 in the past 12 months.

What is Doseology Sciences, Inc.’s market cap?

Doseology Sciences, Inc.’s market cap is C$4.89M.

When is Doseology Sciences, Inc.’s upcoming earnings report date?

Doseology Sciences, Inc.’s upcoming earnings report date is Mar 02, 2026 which is in 8 days.

How were Doseology Sciences, Inc.’s earnings last quarter?

Currently, no data Available

Is Doseology Sciences, Inc. overvalued?

According to Wall Street analysts Doseology Sciences, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Doseology Sciences, Inc. pay dividends?

Doseology Sciences, Inc. does not currently pay dividends.

What is Doseology Sciences, Inc.’s EPS estimate?

Doseology Sciences, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Doseology Sciences, Inc. have?

Doseology Sciences, Inc. has 8,011,621 shares outstanding.

What happened to Doseology Sciences, Inc.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Doseology Sciences, Inc.?

Currently, no hedge funds are holding shares in TSE:MOOD

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Doseology Sciences, Inc.

Doseology Sciences Inc. engages in the cultivation and extraction of nutraceutical and pharmaceutical products in Canada. It focuses on research, development, and sale of medicinal mushroom products, including tinctures and powders. The company sells its products online through doseology.com. Doseology Sciences Inc. was incorporated in 2019 and is based in Kelowna, Canada.